# Primary hyperparathyroidism in a patient with primary aldosteronism

**Authors:** Barish Sarıakjali, Esma Jamaspishvili, Mehtap Evran, Murat Sert, Tamer Tetiker

PMC · DOI: 10.1186/s13104-015-1271-0 · BMC Research Notes · 2015-07-22

## TL;DR

A 38-year-old Turkish man was diagnosed with primary hyperparathyroidism alongside primary aldosteronism, with no identified genetic mutations.

## Contribution

The paper presents a rare case of primary hyperparathyroidism in a patient with primary aldosteronism without genetic mutations.

## Key findings

- The patient had primary hyperparathyroidism and primary aldosteronism (Conn’s syndrome).
- No genetic mutations were identified in the patient or his relatives.
- The case highlights the coexistence of two endocrine disorders without inherited causes.

## Abstract

Primary hyperparathyroidism is one of the most common causes of hypercalcemia. Inherited forms of primary hyperparathyroidism like Multiple Endocrine Neoplasia Type 1, Multiple Endocrine Neoplasia Type 2a, Hyperparathyroidism-Jaw Tumor Syndrome or isolated familial tumors are not common for our population.

We present a case of primary hyperparathyroidism in a 38-year-old Turkish man with hyperaldosteronism (Conn’s syndrome).

Genetic studies could not reveal any mutation. We could not identify any inherit form of the diseases. We wanted the first-line relatives examination of the suspected gene mutation, but they refused.

The online version of this article (doi:10.1186/s13104-015-1271-0) contains supplementary material, which is available to authorized users.

## Linked entities

- **Diseases:** Primary hyperparathyroidism (MONDO:0010837), Primary aldosteronism (MONDO:0001422), Conn’s syndrome (MONDO:0001422), Multiple Endocrine Neoplasia Type 1 (MONDO:0007540), Multiple Endocrine Neoplasia Type 2a (MONDO:0008234), Hyperparathyroidism-Jaw Tumor Syndrome (MONDO:0007768)

## Full-text entities

- **Genes:** IGF1 (insulin like growth factor 1) [NCBI Gene 3479] {aka IGF, IGF-I, IGFI, MGF}, MEN1 (menin 1) [NCBI Gene 4221] {aka MEAI, SCG2}, POMC (proopiomelanocortin) [NCBI Gene 5443] {aka ACTH, CLIP, LPH, MSH, NPP, OBAIRH}, REN (renin) [NCBI Gene 5972] {aka ADTKD4, HNFJ2, RTD}, CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}, PTH (parathyroid hormone) [NCBI Gene 5741] {aka FIH1, PTH1}, GH1 (growth hormone 1) [NCBI Gene 2688] {aka GH, GH-N, GHB5, GHN, IGHD1A, IGHD1B}, PRL (prolactin) [NCBI Gene 5617] {aka GHA1, pPRL}, CALCA (calcitonin related polypeptide alpha) [NCBI Gene 796] {aka CALC1, CGRP, CGRP-I, CGRP-alpha, CGRP1, CT}
- **Diseases:** adenoma (MESH:D000236), Multiple Endocrine Neoplasia Type 1 (MESH:D018761), Hypercalcemia (MESH:D006934), hyperparathyroidism (MESH:D006961), endocrine hypertension (MESH:D006973), Hurthle cell thyroid cancer (MESH:C536913), adrenal adenoma (MESH:D018246), hypokalemia (MESH:D007008), familial tumors (MESH:D009386), Multiple Endocrine Neoplasia Type 2a (MESH:D018813), angiomyolipoma (MESH:D018207), erectile dysfunction (MESH:D007172), biliary tract cancer (MESH:D001661), Hyperparathyroidism-Jaw Tumor Syndrome (MESH:C563273), Conn's syndrome (MESH:D006929), parathyroid adenoma (MESH:D010282), meningioma of the brain (MESH:D008579), West Syndrome (MESH:D013036), Multiple Endocrine Neoplasia syndromes (MESH:D009377), adrenal gland (MESH:D000307), Primary Hyperparathyroidism (MESH:D049950), tumor (MESH:D009369), primary aldosteronism (OMIM:617027)
- **Chemicals:** Ca (MESH:D002118), Na (MESH:D012964), Technetium (99mTc) sestamibi (MESH:D017256), cortisol (MESH:D006854), 25-OH vitamin D3 (-), creatinine (MESH:D003404), Aldosterone (MESH:D000450), K (MESH:D011188), dexamethasone (MESH:D003907), catecholamine (MESH:D002395), glucose (MESH:D005947), spironolactone (MESH:D013148), Mg (MESH:D008274)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC4508971/full.md

## References

6 references — full list in the complete paper: https://tomesphere.com/paper/PMC4508971/full.md

---
Source: https://tomesphere.com/paper/PMC4508971